Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zerilli

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annali Italiani Di Chirurgia|January 1, 1994
[Prognosis and immunomorphological characteristics in rectal cancer: results of a multivariate analysis]A Di Giorgio, C Botti, P Mingazzini, et al.
Minerva Chirurgica|January 31, 1988
[Evaluation of the cellular and humoral immune response in patients with cancer of the esophagus. Preliminary results in 18 cases]M Zerilli, G Luzi, A Moraldi, et al.
Il Giornale Di Chirurgia|August 1, 1997
[Recurrent leiomyoma of the rectum treated by endoscopic transanal microsurgery]M Zerilli, S Lotito, M Scarpini, et al.
European Journal of Nuclear Medicine|September 1, 1994
Technetium-99m sestamibi: an indicator of breast cancer invasivenessF Scopinaro, O Schillaci, M Scarpini, et al.
Current Cancer Drug Targets|June 11, 2009
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myelomaC Tripodo, A M Florena, P Macor, et al.
Journal of Cellular Biochemistry|July 12, 2002
High levels of exogenous C2-ceramide promote morphological and biochemical evidences of necrotic features in thyroid follicular cellsM Todaro, M Catalano, D Di Liberto, et al.
British Journal of Cancer|February 9, 2006
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpretedS Langbein, M Zerilli, A Zur Hausen, et al.
European Journal of Histochemistry : EJH|February 3, 2012
Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapyG Tomasello, C Sciumé, F Rappa, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annali Italiani Di Chirurgia|January 1, 1994
[Prognosis and immunomorphological characteristics in rectal cancer: results of a multivariate analysis]A Di Giorgio, C Botti, P Mingazzini, et al.
Minerva Chirurgica|January 31, 1988
[Evaluation of the cellular and humoral immune response in patients with cancer of the esophagus. Preliminary results in 18 cases]M Zerilli, G Luzi, A Moraldi, et al.
Il Giornale Di Chirurgia|August 1, 1997
[Recurrent leiomyoma of the rectum treated by endoscopic transanal microsurgery]M Zerilli, S Lotito, M Scarpini, et al.
European Journal of Nuclear Medicine|September 1, 1994
Technetium-99m sestamibi: an indicator of breast cancer invasivenessF Scopinaro, O Schillaci, M Scarpini, et al.
Current Cancer Drug Targets|June 11, 2009
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myelomaC Tripodo, A M Florena, P Macor, et al.
Journal of Cellular Biochemistry|July 12, 2002
High levels of exogenous C2-ceramide promote morphological and biochemical evidences of necrotic features in thyroid follicular cellsM Todaro, M Catalano, D Di Liberto, et al.
British Journal of Cancer|February 9, 2006
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpretedS Langbein, M Zerilli, A Zur Hausen, et al.
European Journal of Histochemistry : EJH|February 3, 2012
Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapyG Tomasello, C Sciumé, F Rappa, et al.
Pageof 3